Siu-Fun Wong, PharmD, FASHP, FCSHP, has been invited as a new co-chair for the Drug Development Task Force with the National Cancer Institute (NCI) Symptom Managements and Health-Related Quality of Life Steering Committee.
According to NCI, Dr. Wong will lead the Task Force with Dr. Joanna Brell from NCI to identify and evaluate novel or approved agents that have potentials to provide effective interventions for treatment-induced toxicities and disease-related symptoms. The goals of the Task Force are 1) to increase availability of biologically plausible, pharmacologic intervention for clinical trial assessments in the Clinical Community Oncology Program (CCOP) network, and 2) to provide resource and expertise to facilitate the drug development process.
Also, Dr. Wong has been asked by the Executive Committee of the National Association of Boards of Pharmacy to continue to serve on the North American Pharmacist Licensure Examination (NAPLEX) Review Committee. Committee members are responsible for developing and reviewing the NAPLEX, reviewing examination questions, attending and participating in meetings, and writing new test questions.
The entire School of Pharmacy congratulates Dr. Siu-Fun Wong on these national appointments.